COVID-19 is the important global problem. This new coronavirus can cause several
hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19 …

The aim of this study was to (1) analyze blood viscosity, red blood cell (RBC) deformability,
and aggregation in hospitalized patients with Coronavirus disease 19 (COVID‐19);(2) test …

BACKGROUND: Elevated estimated blood viscosity (EBV), derived from hematocrit and
globulins, is associated with thrombotic complications, organ failure, and higher mortality in …

Coronavirus disease 2019 (COVID-19) is caused by a novel virus known as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2-induced …

Abstract Background Coronavirus disease-2019 (COVID-19) is characterized by a
dysfunctional immune response and abnormal blood rheology that contribute to endothelial …

Background Severe thromboembolic events are one of the major complications associated
with COVID-19 infection, especially among critically ill patients. We analysed ROTEM …

The rate of venous and arterial thrombotic events among patients infected with severe acute
respiratory syndrome coronavirus-2 (SAR-CoV-2) is high. This may be due to a …

Critically ill patients with COVID-19 pneumonia suffered both high thrombotic and bleeding
risk. The effect of SARS-CoV-2 on coagulation and fibrinolysis is not well known. We …

Background Accumulating evidence indicates toward an association between severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and procoagulatory state in …

The review describes pathogenesis of the disease caused by the new SARS-CoV-2 virus. It
infects the human cells by linking angiotensin-converting enzyme-2 (ACE2) and a number of …